NanoString to pay 10x Genomics $68m in global settlement

Biotech rivals agree global patent cross-licences and end all litigation | 10x ‘expects’ to receive $68m plus royalties on sales of its spatial biology products.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

10x Genomics counsel: ‘Winning cases is a top priority’

22 October 2024 10x Genomics senior director of IP and litigation shares her team's tasks, how she’s handling UPC litigation, and why sometimes she wants a ‘gut answer’ from externals, finds Marisa Woutersen.

Unified Patent Court

‘It was like starting all over again’: Tobias Wuttke

1 October 2024 Having been involved in more than 30 cases at the UPC, the Bardehle Pagenberg litigator tells Marisa Woutersen why success at the game-changing court is a team effort.

More features

Is AI emerging as the ‘fourth party’ solving billion-dollar disputes?

Why AI is changing the patent rules faster than anyone can keep up

The hidden code in life sciences deals

LSPN panel unpacks critical IP risks in deal-making

Less is more: patent lawyers flip the script after Amgen

‘Doing more with less’: In-house counsel on budgets and strategy

End of the ‘Death Squad’? Squires puts PTAB on trial

Data and delivery: Inside AI's inventorship dilemma

NanoString to pay 10x Genomics $68m in global settlement

More on this story

Editor's picks

Editor's picks

More features